TAM
NVO

Tocqueville Asset Management’s Novo Nordisk NVO Stock Holding History

Tocqueville Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-52,127
Closed -$4.48M – 546
2024
Q4 		$4.48M Sell
52,127
-40,149
-44% -$4.34M 0.07% 194
2024
Q3 		$11M Sell
92,276
-2,056
-2% -$274K 0.17% 133
2024
Q2 		$13.5M Sell
94,332
-10,115
-10% -$1.34M 0.22% 112
2024
Q1 		$13.4M Sell
104,447
-251
-0.2% -$29.9K 0.22% 114
2023
Q4 		$10.8M Buy
104,698
+102,128
+3,974% +$10.1M 0.2% 123
2023
Q3 		$234K Hold
2,570
– – ﹤0.01% 473
2023
Q2 		$208K Hold
2,570
– – ﹤0.01% 503
2023
Q1 		$204K Buy
+2,570
New +$182K ﹤0.01% 502
2020
Q2 		– Sell
-7,870
Closed -$237K – 672
2020
Q1 		$237K Buy
+7,870
New +$234K 0.01% 572
2014
Q3 		– Sell
-5,700
Closed -$132K – 1136
2014
Q2 		$132K Buy
+5,700
New +$126K ﹤0.01% 1082

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Tocqueville Asset Management's NVO Position: Q1 2025 in Review

Tocqueville Asset Management sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 52,127 shares — an estimated $4.48M sold.

Tocqueville Asset Management first reported a position in NVO in Q2 2014 and held it in 10 quarters. The position peaked at $13.5M in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Tocqueville Asset Management reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Tocqueville Asset Management sold 52,127 Novo Nordisk shares in Q1 2025, an estimated $4.48M.
  • Tocqueville Asset Management first reported a position in Novo Nordisk in Q2 2014 and held it in 10 quarters.
  • Tocqueville Asset Management's Novo Nordisk position peaked at $13.5M in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Tocqueville Asset Management's 13F filing for Q1 2025, filed 13 May 2025.